NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has reached a settlement with direct-to-consumer genetic testing firm Navigenics and subsequently reached a licensing agreement for a patent related to methods of analyzing non-coding DNA sequences.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.